Hantavirus as a persistent zoonotic risk: epidemiology and current pharmacological management. [PDF]
Di Maria S, Provenzani A.
europepmc +1 more source
Assessing Evidence to Guide Primary Prevention of Pathogen X. [PDF]
Holmes I +6 more
europepmc +1 more source
From Vulnerability to Hope: Experiences with COVID-19 over Time in Rural America. [PDF]
Denu Y +5 more
europepmc +1 more source
Clinical Manifestations of Hemorrhagic Fever with Renal Syndrome, Various Nosologic Forms and Issues of Hantavirus Infections Terminology. [PDF]
Tkachenko E +8 more
europepmc +1 more source
Increasing spatial scale of analysis weakens and can mask the dilution effect for hantaviruses. [PDF]
Vigueras-Galván AL +12 more
europepmc +1 more source
Remodelling of P-bodies and the cytoskeleton by <i>Orthohantavirus puumalaense</i> (Puumala virus). [PDF]
Schwarzer-Sperber HS +13 more
europepmc +1 more source
Hantavirus on the rise: clinical, virological, immunological, and public health perspectives. [PDF]
Acharya A +3 more
europepmc +1 more source
Special Issue on Efficacy, Safety, and Immunogenicity of Vaccines Against Viruses: From Network Medicine to Clinical Experimentation. [PDF]
Hiram Guzzi P, Das JK, Milano M.
europepmc +1 more source
A retrospective evaluation of the BIOFIRE FilmArray Blood Culture Identification 2 panel for the detection of pathogenic yeasts. [PDF]
Puumala E +3 more
europepmc +1 more source

